Shifting the focus from symptom-based diagnosis to biomarker-based diagnosis is the general goal of psychiatry and neurodegeneration research. This workshop seeks to explore the potential of magnetic resonance imaging and spectroscopy for identifying and utilizing biomarkers useful for diagnosing mental illnesses and neurodegenerative diseases, aiming to enhance the precision and reliability of psychiatric and neurodegenerative diagnoses. MR neuroimaging, especially with recent advances in imaging techniques, is a powerful tool that provides structural, functional, and molecular information about the brain. Together with dedicated acquisition schemes, system manipulations, novel analysis tools, and translational approaches, it offers significant potential to identify imaging biomarkers for psychiatric and neurodegenerative disorders.
Through collaborative discussions and presentation sessions, participants will engage with the latest research, MR technologies, and methodologies in the field of psychiatric and neurodegenerative biomarkers, aiming to foster advancements in diagnostic accuracy and patient outcomes.
International Society for Magnetic Resonance in Medicine2300 Clayton Road, Suite 620 | Concord, CA, 94520 USA
Phone: +1.510.841.1899Fax: +1.510.841.2340e-mail: info@ismrm.org
Join TodayBenefits
About UsTerms of Use